TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.5, ss.1559-1568, 2022 (SCI-Expanded)
Background/aim: The aim of our study was to compare the efficacy and the safety of the FLOT and the modified DCF (mDCF) regimens in patients with metastatic gastric (GC) and gastroesophageal junction (GEJ) adenocarcinoma as first-line treatment.